Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing

Antolin Llorente, Craig L. Jensen, Robert G. Voigt, J. Kennard Fraley, Marcia C. Berretta, William C. Heird

Research output: Contribution to journalArticle

146 Citations (Scopus)

Abstract

OBJECTIVE: The purpose of this study was to determine the effect of docosahexaenoic acid supplementation on plasma phospholipid docosahexaenoic acid content and indices of depression and information processing for women who breast-feed. STUDY DESIGN: Mothers who planned to breast-feed their infants weie assigned randomly in a double-masked fashion to receive either docosahexaenoic acid (≈200 mg/d) or placebo for the first 4 months after the delivery. Major outcome variables included plasma phospholipid fatty acid patterns and scores on a self-rating questionnaire of current depression symptoms. A structured clinical interview of depression, scores on another self-rating questionnaire of depression symptoms, and a laboratory measure of information processing were obtained in subgroups of the total population. RESULTS: Plasma phospholipid contents of docosahexaenoic acid at baseline were 3.15 ± 0.78 and 3.31 ± 0.70 (mg/dL of total fatty acids) in the docosahexaenoic acid and placebo groups, respectively. After 4 months, the plasma phospholipid docosahexaenoic acid content of the docosahexaenoic acid group was 8% higher (3.40 ± 0.97 mg/dL), whereas that of the placebo group was 31% lower (2.27 ± 0.87 mg/dL). Despite the higher plasma phospholipid docosahexaenoic acid content of the supplemented group after 4 months, there was no difference between groups in either self-rating or diagnostic measures of depression; information processing scores of the two groups also did not differ. CONCLUSION: Docosahexaenoic acid supplementation (≈200 mg/d) for 4 months after the delivery prevented the usual decline in plasma phospholipid docosahexaenoic acid content of women who breastfeed but did not influence self-ratings of depression, diagnostic measures of depression, or information processing.

Original languageEnglish (US)
Pages (from-to)1348-1353
Number of pages6
JournalAmerican journal of obstetrics and gynecology
Volume188
Issue number5
DOIs
StatePublished - May 1 2003

Fingerprint

Postpartum Depression
Docosahexaenoic Acids
Automatic Data Processing
Mothers
Phospholipids
Depression
Placebos
Breast
Fatty Acids
Interviews

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynecology

Cite this

Llorente, Antolin ; Jensen, Craig L. ; Voigt, Robert G. ; Fraley, J. Kennard ; Berretta, Marcia C. ; Heird, William C. / Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. In: American journal of obstetrics and gynecology. 2003 ; Vol. 188, No. 5. pp. 1348-1353.
@article{e5a9f0512a2d4b4fb36d3b8b690672f3,
title = "Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing",
abstract = "OBJECTIVE: The purpose of this study was to determine the effect of docosahexaenoic acid supplementation on plasma phospholipid docosahexaenoic acid content and indices of depression and information processing for women who breast-feed. STUDY DESIGN: Mothers who planned to breast-feed their infants weie assigned randomly in a double-masked fashion to receive either docosahexaenoic acid (≈200 mg/d) or placebo for the first 4 months after the delivery. Major outcome variables included plasma phospholipid fatty acid patterns and scores on a self-rating questionnaire of current depression symptoms. A structured clinical interview of depression, scores on another self-rating questionnaire of depression symptoms, and a laboratory measure of information processing were obtained in subgroups of the total population. RESULTS: Plasma phospholipid contents of docosahexaenoic acid at baseline were 3.15 ± 0.78 and 3.31 ± 0.70 (mg/dL of total fatty acids) in the docosahexaenoic acid and placebo groups, respectively. After 4 months, the plasma phospholipid docosahexaenoic acid content of the docosahexaenoic acid group was 8{\%} higher (3.40 ± 0.97 mg/dL), whereas that of the placebo group was 31{\%} lower (2.27 ± 0.87 mg/dL). Despite the higher plasma phospholipid docosahexaenoic acid content of the supplemented group after 4 months, there was no difference between groups in either self-rating or diagnostic measures of depression; information processing scores of the two groups also did not differ. CONCLUSION: Docosahexaenoic acid supplementation (≈200 mg/d) for 4 months after the delivery prevented the usual decline in plasma phospholipid docosahexaenoic acid content of women who breastfeed but did not influence self-ratings of depression, diagnostic measures of depression, or information processing.",
author = "Antolin Llorente and Jensen, {Craig L.} and Voigt, {Robert G.} and Fraley, {J. Kennard} and Berretta, {Marcia C.} and Heird, {William C.}",
year = "2003",
month = "5",
day = "1",
doi = "10.1067/mob.2003.275",
language = "English (US)",
volume = "188",
pages = "1348--1353",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "5",

}

Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. / Llorente, Antolin; Jensen, Craig L.; Voigt, Robert G.; Fraley, J. Kennard; Berretta, Marcia C.; Heird, William C.

In: American journal of obstetrics and gynecology, Vol. 188, No. 5, 01.05.2003, p. 1348-1353.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing

AU - Llorente, Antolin

AU - Jensen, Craig L.

AU - Voigt, Robert G.

AU - Fraley, J. Kennard

AU - Berretta, Marcia C.

AU - Heird, William C.

PY - 2003/5/1

Y1 - 2003/5/1

N2 - OBJECTIVE: The purpose of this study was to determine the effect of docosahexaenoic acid supplementation on plasma phospholipid docosahexaenoic acid content and indices of depression and information processing for women who breast-feed. STUDY DESIGN: Mothers who planned to breast-feed their infants weie assigned randomly in a double-masked fashion to receive either docosahexaenoic acid (≈200 mg/d) or placebo for the first 4 months after the delivery. Major outcome variables included plasma phospholipid fatty acid patterns and scores on a self-rating questionnaire of current depression symptoms. A structured clinical interview of depression, scores on another self-rating questionnaire of depression symptoms, and a laboratory measure of information processing were obtained in subgroups of the total population. RESULTS: Plasma phospholipid contents of docosahexaenoic acid at baseline were 3.15 ± 0.78 and 3.31 ± 0.70 (mg/dL of total fatty acids) in the docosahexaenoic acid and placebo groups, respectively. After 4 months, the plasma phospholipid docosahexaenoic acid content of the docosahexaenoic acid group was 8% higher (3.40 ± 0.97 mg/dL), whereas that of the placebo group was 31% lower (2.27 ± 0.87 mg/dL). Despite the higher plasma phospholipid docosahexaenoic acid content of the supplemented group after 4 months, there was no difference between groups in either self-rating or diagnostic measures of depression; information processing scores of the two groups also did not differ. CONCLUSION: Docosahexaenoic acid supplementation (≈200 mg/d) for 4 months after the delivery prevented the usual decline in plasma phospholipid docosahexaenoic acid content of women who breastfeed but did not influence self-ratings of depression, diagnostic measures of depression, or information processing.

AB - OBJECTIVE: The purpose of this study was to determine the effect of docosahexaenoic acid supplementation on plasma phospholipid docosahexaenoic acid content and indices of depression and information processing for women who breast-feed. STUDY DESIGN: Mothers who planned to breast-feed their infants weie assigned randomly in a double-masked fashion to receive either docosahexaenoic acid (≈200 mg/d) or placebo for the first 4 months after the delivery. Major outcome variables included plasma phospholipid fatty acid patterns and scores on a self-rating questionnaire of current depression symptoms. A structured clinical interview of depression, scores on another self-rating questionnaire of depression symptoms, and a laboratory measure of information processing were obtained in subgroups of the total population. RESULTS: Plasma phospholipid contents of docosahexaenoic acid at baseline were 3.15 ± 0.78 and 3.31 ± 0.70 (mg/dL of total fatty acids) in the docosahexaenoic acid and placebo groups, respectively. After 4 months, the plasma phospholipid docosahexaenoic acid content of the docosahexaenoic acid group was 8% higher (3.40 ± 0.97 mg/dL), whereas that of the placebo group was 31% lower (2.27 ± 0.87 mg/dL). Despite the higher plasma phospholipid docosahexaenoic acid content of the supplemented group after 4 months, there was no difference between groups in either self-rating or diagnostic measures of depression; information processing scores of the two groups also did not differ. CONCLUSION: Docosahexaenoic acid supplementation (≈200 mg/d) for 4 months after the delivery prevented the usual decline in plasma phospholipid docosahexaenoic acid content of women who breastfeed but did not influence self-ratings of depression, diagnostic measures of depression, or information processing.

UR - http://www.scopus.com/inward/record.url?scp=0038733905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038733905&partnerID=8YFLogxK

U2 - 10.1067/mob.2003.275

DO - 10.1067/mob.2003.275

M3 - Article

C2 - 12748510

AN - SCOPUS:0038733905

VL - 188

SP - 1348

EP - 1353

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 5

ER -